Quick Answer
TANDEM DIABETES CARE INC reported Net Income of -$204.71 million for fiscal year 2025.
TANDEM DIABETES CARE INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$204.71M | -113.2% |
| 2024 | -$96.03M | +56.9% |
| 2023 | -$222.61M | -135.3% |
| 2022 | -$94.59M | -707.7% |
| 2021 | $15.57M | +145.3% |
| 2020 | -$34.38M | -38.9% |
| 2019 | -$24.75M | +79.8% |
| 2018 | -$122.61M | -67.9% |
| 2017 | -$73.03M | +12.5% |
| 2016 | -$83.45M | -15.2% |
| 2015 | -$72.42M | +8.9% |
| 2014 | -$79.52M | -26.0% |
| 2013 | -$63.14M | -91.2% |
| 2012 | -$33.02M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$21.16M | +9.0% | +59.6% |
| June 30, 2025 | -$52.40M | -70.1% | +59.9% |
| March 31, 2025 | -$130.56M | -205.6% | -461.5% |
| September 30, 2024 | -$23.25M | +29.5% | +24.5% |
| June 30, 2024 | -$30.81M | +13.9% | +27.9% |
| March 31, 2024 | -$42.72M | +65.5% | -29.6% |
| September 30, 2023 | -$32.96M | +32.7% | +7.9% |
| June 30, 2023 | -$35.77M | -137.6% | +71.1% |
- TANDEM DIABETES CARE INC showed a decrease of -113.2% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, TANDEM DIABETES CARE INC’s net income has declined by 520.1% (from -$33.02 million to -$204.71 million).
- The most recent figure is from TANDEM DIABETES CARE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: